Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 2/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL11412719 | 0.88 | ACLY (0.32) | ALDH1A1L3MBTL1FOLH1ACLYACE | |
| Trifluoroacetic Acid SCHEMBL29736079 | 0.85 | TSHR (0.44) | ALDH1A1THRBSMN1; SMN2CA2TSHR | |
| Trifluoroacetic Acid SCHEMBL5470574 | 0.84 | FAAH (0.39) | ALDH1A1L3MBTL1ACLYCES1TSHR | |
| Trifluoroacetic Acid SCHEMBL7814389 | 0.82 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1ACLYTHRBCES1 | |
| Trifluoroacetic Acid SCHEMBL30657022 | 0.82 | — | — | |
| Trifluoroacetic Acid SCHEMBL2484766 | 0.82 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1ACLYTHRBCES1 | |
| Trifluoroacetic Acid SCHEMBL474 | 0.82 | — | — | |
| Trifluoroacetic Acid SCHEMBL4598430 | 0.82 | — | — | |
| Trifluoroacetic Acid SCHEMBL21046071 | 0.79 | DPP8 (0.31) | — | |
| Trifluoroacetic Acid SCHEMBL28235039 | 0.79 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1ACLYTHRBCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11560402-B2 | Method for cleavage of solid phase-bound peptides from the solid phase | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2023-01-24 | — | — | US | disclosed |
| EP-3774838-B1 | LIXISENATIDE SYNTHESIS WITH CAPPING | SANOFI AVENTIS DEUTSCHLAND (DE) | 2022-08-10 | — | — | EP | disclosed |
| US-11028123-B2 | Capping of unprotected amino groups during peptide synthesis | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2021-06-08 | — | — | US | disclosed |
| US-20190330266-A1 | METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11560402-B2 | Method for cleavage of solid phase-bound peptides from the solid phase | VIP, PTMS, CTRC | ALDH1A1 4161/4885L3MBTL1 1923/4885FOLH1 159/4885 |
| US-20190330266-A1 | METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE | VIP, PTMS, CTRC | ALDH1A1 4161/4885L3MBTL1 1923/4885FOLH1 159/4885 |
| US-11028123-B2 | Capping of unprotected amino groups during peptide synthesis | RNGTT, ANPEP, DNPEP | ALDH1A1 4398/4885L3MBTL1 771/4885FOLH1 577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.